Registration of protocols for observational research is unnecessary and would do more harm than good

Occupational and Environmental Medicine

Volumn 68, Issue 2, 2011, Pages 86-88

  Pearce, Neil ^a,b  

^a MASSEY UNIVERSITY   (New Zealand)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; CLINICAL PRACTICE; ERROR; HEALTH CARE POLICY; LIFESTYLE; MASS MEDIUM; METHODOLOGY; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; PUBLICATION; REGISTRATION; SCIENTIFIC LITERATURE;

BIOMEDICAL RESEARCH; CLINICAL PROTOCOLS; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; EPIDEMIOLOGIC STUDIES; HUMANS; OBSERVATION; REGISTRIES; RESEARCH DESIGN;

EID: 78751677089     PISSN: 13510711     EISSN: 14707926     Source Type: Journal    
DOI: 10.1136/oem.2010.058917     Document Type: Note

References (39)

1. Taubes G. Epidemiology faces its limits. Science 1995;269:164.
2. Hempel S. The strange Case Of The Broad Street Pump: John Snow And The Mystery Of Cholera. Berkeley, CA: University of California Press, 2007.
3. IARC. Tobacco smoking and involuntary tobacco smoke. IARC Monographs on the evaluation of the carcinogenic risks to humans, vol. 83. Lyon: International Agency for Research on Cancer, 2004.
4. IARC. Asbestos. IARC Monographs on the evaluation of the carcinogenic risks to humans, vol. 14. Lyon: International Agency for Research on Cancer, 1977.
5. IARC. Human papilloma viruses. IARC Monographs on the evaluation of carciongenic risks to humans, vol. 64. Lyon: International Agency for Research on Cancer, 1995.
6. Davey Smith G, Ebrahim S. Data dredging, bias, or confounding: they can all get you into the BMJ and the Friday papers. Br Med J 2002;325:1437-8.
7. Davey Smith G, Ebrahim S. Epidemiology - is it time to call it a day?. Int J Epidemiol 2001;301:1-11.
8. Pearce N. Corporate influences on epidemiology. Int J Epidemiol 2008;37:46-53.
9. Siemiatycki J, Wacholder S, Dewar R, et al. Smoking and degree of occupational exposure: are internal analyses in cohort studies likely to be confounded by smoking status? Am J Ind Med 1988;13:59-69.
10. Greenland S. The need for critical appraisal of expert witnesses in epidemiology and statistics. Wake Forest Law Rev 2004;39:291-310.
11. Michaels D, Monforton C. Manufacturing uncertainty: contested science and the protection of the public's health and environment. Am J Public Health 2005;95:S39-48.
12. Pearce N. Adverse Reactions: The Fenoterol Story. Auckland: Auckland University Press, 2007.
13. Infante PF. The past suppression of industry knowledge of the toxicity of benzene to humans and potential bias in future benzene research. Int J Occup Environ Health 2006;12:268-72.
14. Monforton C. Weight of the evidence or wait for the evidence? Protecting underground miners from Diesel particulate matter. Am J Public Health 2006;96:271-6.
15. Hardell L, Walker MJ, Walhjalt B, et al. Secret ties to industry and conflicting interests in cancer research. Am J Ind Med 2006. doi:10.1002/ajim.20357.
16. Michaels D, Monforton C, Lurie P. Selected science: an industry campaign to undermine an OSHA hexavalent chromium standard. Environ Health 2006;5:10.1186/1476-069X-5-5.
17. Egilman D. Corporate corruption of science - The case of chromium(VI). Int J Occup Environ Health 2006;12:169-76.
18. Boffetta P, McLaughlin JK, La Vecchia C, et al. False-positive results in cancer epidemiology: a plea for epistemological modesty. J Natl Cancer Inst 2008;100:988-95.
19. Blair A, Saracci R, Vineis P, et al. Epidemiology, Public Health, and the Rhetoric of False Positives. Environ Health Perspect 2009;117:1809-13.
20. Chemicals ECfEaTo. Workshop Report number 18: enhancement of the scientific process and transparency of observational studies. Brussels: European Centre for Ecotoxicology and Toxicology of Chemicals, 2009.
21. Rushton L. Should protocols for observational research be registered? Occup Environ Med 2011;68:84-86.
22. Lash TL. Preregistration of study protocols is unlikely to improve the yield from our science, but other strategies might. Epidemiology 2010;21:612-13.
23. Poole C. A vision of accessible epidemiology. Epidemiology 2010;21:616-18.
24. Samet JM. To register or not register. Epidemiology 2010;21:610-11.
25. Sorensen HT, Rothman KJ. The prognosis for research. Br Med J 2010:340.
26. Takkouche B, Norman G. Meta-analysis protocol registration: Sed quis custodiet ipsos custodes? [But who will guard the guardians?]. Epidemiology 2010;21:614-15.
27. Vandenbroucke JP. Registering observational research: second thoughts. Lancet 2010;375:982-3.
28. Vandenbroucke JP. Preregistration of epidemiologic studies: an illfounded mix of ideas. Epidemiology 2010;21:619-20.
29. Should protocols for observational research be registered? Lancet 2010;375:348.
30. Loder E, Groves T, MacAuley D. Registration of observational studies. Br Med J 2010:340.
31. IEA. Good Epidemiological Practice (GEP). http://www.ieaweb.org/iea/good- epidemiological-practice.html. 2007.
32. von Elm E, Altman DG, Pocock SJ, et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Br Med J 2007;335:806-8.
33. Horton R. Vioxx, the implosion of Merck, and aftershocks at the FDA. Lancet 2004;364:1995-6.
34. Topol EJ. Failing the public health - Rofecoxib, Merck, and the FDA. N Engl J Med 2004;351:1707-9.
35. Pearce N, Douwes J. Response: Time for species-course epidemiology. Int J Epidemiol 2009;38:403-10.
36. Greenland S. Multiple comparisons and association selection in general epidemiology. Int J Epidemiol 2008;37:430-4.
37. IARC. IARC Monographs on the evaluation of the carcinogenic risks to humans, vols. 1-99. Lyon: International Agency for Research on Cancer, 1972-2010.
38. Watson JD. The double helix: a personal account of the discovery of the structure of DNA. New York: Simon & Schuster, 1968.
39. Pearce N. The rise and rise of corporate epidemiology and the narrowing of epidemiology's vision. Int J Epidemiol 2007;36:713-17.